2nd Quarter - Report

BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY

Firm
Client
Income
—
Expenses
$980,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R. 4213, Tax Extenders Act - Lobbied for passage of the R&D Tax Credit and other favorable tax provisions. NO BILL, Tax Reform - Lobbied to gather information on potential legislation regarding deferral of foreign income.

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —
LANE PENRY —
CHRISTOPHER PERNIE —

Contacted: Treasury, Dept of; Health Resources & Services Administration (HRSA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4213 (111th)

Copyright/Patent/Trademark CPT

S. 515 and H.R. 1260, Patent Reform Act of 2009 - Lobbied to improve provisions related to inequitable conduct and damages. S. 369 and H.R. 706, Preserve Access to Affordable Generics Act - Lobbied to oppose banning patent settlements.

LobbyistCovered position, as disclosed
LANE PENRY —
CHRISTOPHER PERNIE —

Contacted: Health Resources & Services Administration (HRSA); SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES

Bills named: H.R. 706 (111th), S. 369 (111th), H.R. 1260 (111th), S. 515 (111th)

Health Issues HCR

S. 525, S. 1232, and H.R. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of bill. H.R. 1438, Promoting Increased Awareness and Diagnosis of Peripheral Arterial Disease (PAD) to Address the High Mortality Rate of this Treatable Disease - Lobbied for passage of bill. NO BILL, Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drugs Assistance Program. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program and the nee Fee on pharmaceutical sales in government programs.

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —
LANE PENRY —
CHRISTOPHER PERNIE —

Contacted: Treasury, Dept of; SENATE; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1438 (111th), H.R. 1232 (111th), S. 1232 (111th), H.R. 3974 (111th), S. 525 (111th)

Medicare/Medicaid MMM

S. 565 and H.R. 1485, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - Lobbied for passage of bills. S. 254 and H.R. 547, Medicare Home Infusion Therapy Coverage Act - Lobbied for passage of bill.

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —
LANE PENRY —
CHRISTOPHER PERNIE —

Contacted: Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA)

Bills named: H.R. 1485 (111th), H.R. 547 (111th), S. 565 (111th), S. 254 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.